Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National Conference taking place from November 1 – 3, 2023.
- "We are pleased to be presenting at the Ovarian Cancer National Conference," said Dr. Amit Kumar, Chairman and CEO of Anixa Biosciences.
- "We look forward to providing an overview of our Phase 1 ovarian cancer trial to an audience which is highly interested in new therapies to battle ovarian cancer."
- The Ovarian Cancer National Conference is organized by the Ovarian Cancer Research Alliance ("OCRA").
- The organization has invested $100 million in ovarian cancer research, educated 95,000 medical professionals, and advocated for $200 million in government research and education funding.